Title

Feasibility of synchrotron radiation computed tomography on rats bearing glioma after iodine or gadolinium injection

RIS ID

76656

Publication Details

Le Duc, G., Corde, S., Elleaume, H., Esteve, F., Charvet, A., Brochard, T., Fiedler, S., Collomb, A. & Le Bas, J. (2000). Feasibility of synchrotron radiation computed tomography on rats bearing glioma after iodine or gadolinium injection. European Radiology, 10 (9), 1487-1492.

Abstract

The purpose of this work was to demonstrate the feasibility of a new imaging technique called synchrotron radiation computed tomography (SRCT). This technique leads to a direct assessment of the in vivo concentration of an iodine- or gadolinium-labeled compound. Rats bearing C6 glioma were imaged by MRI prior to the SRCT experiment. The SRCT experiments were performed after a 1.3 g I/kg (n = 5) or a 0.4 g Gd/kg (n = 5) injection. Finally, brains were sampled for histology. The SRCT images exhibited contrast enhancement at the tumor location. Ten minutes after injection, iodine and gadolinium tissular concentrations were equal to 0.80 ( +/- 0.40) mg/cm3 and 0.50 ( +/- 0.10) mg/cm3, respectively in the peripheral area of the tumor (respective background value: 0.20 +/- 0.02 to 0.10 +/- 0.01). Correlation to MRI and histology revealed that the contrast uptake occurred in the most vascularized area of the tumor. The present study summarizes the feasibility of in vivo SRCT to obtain quantitative information about iodine and gadolinium-labeled compounds. Beyond brain tumor pathology, the SRCT appears as a complementary approach to MRI and CT, for studying iodine- and gadolinium-labeled compounds by the direct achievement of the tissular concentration value in the tissue.

Please refer to publisher version or contact your library.

Share

COinS